7 results for Conium maculatum (poison-hemlock)

Impact ID Scientific Name Impact Type Study Type Study Location Impact Description Geographic Location Reference
7945 Conium maculatum Research Anecdotal N/A Extracts of Conium maculatum (poison hemlock) have been used medicinally for many years in treating tumors, ulcers, and gout. 25389
7946 Conium maculatum Research Anecdotal N/A Conium maculatum (poison hemlock) has ultimately very limited medicinal importance due to the narrow distinction between therapeutic and toxic levels of administration. 25279
7947 Conium maculatum Research Anecdotal N/A Coniine hydrobromide, derived from Conium maculatum (poison hemlock), is used as an antispasmodic. 25383
7948 Conium maculatum Research Experimental Laboratory Ultra-diluted natural Conium remedies used in India were tested to see if Conium maculatum (poison hemlock) had inhibitory effects on breast cancer. These remedies caused cell cycle delay/arrest and apoptosis of the two breast cancer cell lines tested. 25290
7949 Conium maculatum Research Experimental Laboratory Mixtures of alkaloid-containing water-alcohol extracts from Conium maculatum (poison hemlock) and salicylic acid inhibit symptoms of inflammation (exudation, pain, fever) to the same extent as conventional non-steroidal anti-inflammatory treatments. It is believed that these substances could be an alternative treatment for pain caused by various inflammatory conditions. 25294
7950 Conium maculatum Research Experimental Laboratory Conmaculation, a piperidine alkaloid found in Conium maculatum (poison hemlock), exhibited strong antinocicpetive activity in mice. However, doses over 20mg/kg were lethal. 25298
7951 Conium maculatum Research Experimental Laboratory Conmaculation extracted from Conium maculatum (poison hemlock) does not seem to affect locomotor skills. 25282

Currently showing impact type "Research".

View all impact types for Conium maculatum